 | |
| Company type | Subsidiary |
|---|---|
| Industry | Pharmaceuticals |
| Founded | 1961 |
| Founders | Ranbir Singh Gurbax Singh |
| Defunct | 2014 |
| Fate | Acquired by Sun Pharma |
| Successor | Sun Pharmaceuticals |
| Headquarters | , India |
Key people |
|
Number of employees | 10,983 (2012)[1] |
| Parent | Sun Pharmaceuticals |
Ranbaxy Laboratories Limited was an Indian multinational pharmaceutical company that was incorporated in India in 1961 and remained an entity until 2014. The company went public in 1973. Ownership of Ranbaxy changed twice over the course of its history.
In 2008, Japanese pharmaceutical company Daiichi Sankyo acquired a controlling share in Ranbaxy[2] and in 2014, Sun Pharma acquired 100% of Ranbaxy in an all-stock deal. The Sun Pharma acquisition brought all new management to Ranbaxy, which had been laden with controversy (see Controversies below). Sun is the world's fifth largest specialty generic pharmaceutical company.[3]
- ^ "Annual Report 2012" (PDF). Ranbaxy Laboratories Limited. Archived from the original (PDF) on 5 November 2013.
- ^ Matsuyama, Kanoko; Chatterjee, Saikat (11 June 2008). "Daiichi to Take Control of Ranbaxy for $4.6 Billion (Update3) - Bloomberg". Bloomberg.com. Bloomberg LP. Archived from the original on 2 December 2014. Retrieved 11 August 2018.
- ^ Cite error: The named reference
bpwas invoked but never defined (see the help page).